Lannett Company Competitors
| Ticker | Name | Consensus | Stock Rating | Price | Price Target | Upside/Downside | Analysts | Market Cap |
|---|---|---|---|---|---|---|---|---|
| TEVA | Teva Pharmaceutical Industries | Outperform |
12
|
$16.78 | $11.59 | 1.31% | 9 | $19.01B |
| AUROPHARMA | Aurobindo Pharma | Outperform |
18
|
Rp1.16k | Rp1.09k | 1.86% | 20 | Rp653.50B |
| APN | Aspen Pharmacare Holdings | Outperform |
18
|
R230.10 | R202.49 | 2.19% | 1 | R102.44B |
| HIK | Hikma Pharmaceuticals PLC | Outperform |
18
|
£20.28 | £28.11 | 44.03% | 9 | £4.42B |
| RICHTER | Outperform |
18
|
Ft9.45k | Ft11.02k | 23.88% | 2 | Ft1.75T | |
| PRGO | Perrigo Co PLC | Outperform |
16
|
$30.22 | $44.75 | 32.36% | 0 | $4.19B |
| KRKG | Krka, d. d. | Buy |
18
|
125.00€ | 119.80€ | 14.00% | 0 | 3.84€B |
| GLENMARK | Glenmark Pharmaceuticals | Outperform |
18
|
Rp1.00k | Rp767.80 | -9.77% | 9 | Rp282.09B |
| AMRX | Amneal Pharmaceuticals | Outperform |
16
|
$6.87 | $6.13 | 16.45% | 1 | $2.09B |
| AMPH | Amphastar Pharmaceuticals | Outperform |
14
|
$42.44 | $69.00 | 46.09% | 0 | $2.09B |
| SUPN | Supernus Pharmaceuticals | Outperform |
16
|
$28.74 | $41.00 | 42.66% | 0 | $1.72B |
| AIP | Adcock Ingram Holdings | Hold |
16
|
R55.26 | R55.97 | 1.34% | 1 | R8.41B |
| CHRS | Coherus BioSciences | Outperform |
6
|
$2.18 | $10.86 | 266.97% | 3 | $255.37M |
| ASRT | Assertio Holdings | Buy |
8
|
$1.01 | $3.50 | 197.03% | 2 | $100.36M |